Scinai Immunotherapeutics Ltd. American Depositary Shares Skyrocketed
Mon, Jun 17, 2024 at 07:12 PM
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ) jumped higher at $5.6, representing a gain of 60.5%. On Mon, Jun 17, 2024, SCNI:NASDAQ hit a New 2-Week High of $5.6. The stock got featured on our News Catalysts scanner on Thu, Jun 13, 2024 at 10:31 AM in the 'AGREEMENT' category. From Mon, Jun 03, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days
About Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ)
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine.
Top 10 Gainers:
- Mustang Bio, Inc. (MBIO:NASDAQ), 476.92%
- Movella Holdings Inc Com (MVLA:NASDAQ), 75.83%
- Interactive Strength Inc. (TRNR:NASDAQ), 71.33%
- Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI:NASDAQ), 60.46%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Azitra Inc (AZTR:NYSEMKT), 56.53%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Trxade Group, Inc. (MEDS:NASDAQ), 41.28%
- Xponential Fitness Inc. Class A (XPOF:NYSE), 34.25%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 34.17%